Generics 32

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Rocuronium bromide manufacturers

32 products found

Filters

32 products found

rocuronium bromide

Solution for injection 10 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United Arab Emirates , Croatia
Manufacturer #12799
It is a generic pharmaceutical producer and sales organization based in Western Europe that was created in the 1990s. The company's broad portfolio includes high-quality complex dosage forms, such as liquid, injectable, dry powder, and lyophilisate items, and it specializes in supplying hospitals and pharmacies with selected products. It continues to grow steadily, and its focus on high-quality items, excellent service, and the development of strong relationships remains strong, attesting to the company's reputation.

Manufacturer usually replies in 5 days

rocuronium bromide

Solution for injection 50 mg/5 ml, 75 mg/7.5 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #17737

Manufacturer usually replies in 5 days

rocuronium bromide

Solution for injection 50 mg/5 ml, 100 mg/10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #13095

Manufacturer usually replies in 5 days

rocuronium bromide

Vials, injection 50 mg/5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 5 days

rocuronium bromide

Vials, injection 50 mg/5 ml, 100 mg/10 ml - 10 ml, 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Manufacturer #2272
The company integrates and applies enormous experience and technology in the field of hospital products. Their goal is to become a global leader in intensive care units and maintain that position. The company's headquarters were established in Europe in 1980ies, and serum production was continuing in a plant in Europe till the end of the 2000s. With a nationwide market share of 50%, it has become one of the leading serum producers. They've already started making the first ready-to-use injections.

Manufacturer usually replies in 7 days

rocuronium bromide

Solution for injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PICS
Manufacturer #21567

Manufacturer usually replies in 2 days

rocuronium bromide

Solution for injection 50mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Unavailable markets
Germany , Taiwan
Manufacturer #11630

Manufacturer usually replies in 4 days

rocuronium bromide

Solution for injection 50 mg/5 ml, 100 mg/10 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
FDA
Manufacturer #13095

Manufacturer usually replies in 5 days

rocuronium bromide

Vials, injection 10 mg/ml - 5 ml, 10 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Comments
ANDA / R &D Status: Approved; US RLD / Holder: "Zemuron / Organon USA INC"; Indication: Neuromuscular Blocker. Used as skeletal muscle relaxant during surgery;
Manufacturer #8216

Manufacturer usually replies in 6 days

rocuronium bromide

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

rocuronium bromide

Solution for injection 50mg/5ml - 5ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Available for
Licensing with supply, Distribution only
Manufacturer #17771

Manufacturer usually replies in 3 days

rocuronium bromide

Vials, injection 50 mg / 5 mL - 5 mL

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Registered in
United States
Available for
Distribution only
Manufacturer #31361

rocuronium bromide

Vials 10 mg/ml - 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
GMP, WHO
Manufacturer #24869

Manufacturer usually replies in 3 days

rocuronium bromide

Injection 10 mg/ml - 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20982

Manufacturer usually replies in 8 days

rocuronium bromide

Injection 50 mg / 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
COFEPRIS
Manufacturer #18736
It was founded in the 2000s. The main aim of the position itself in the market as a company dedicated to the research, development, manufacturing, marketing, and distribution of new generation specialized generic and biosimilar medicines.

Manufacturer usually replies in 7 days

rocuronium bromide

Injection 50mg/5ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18256

Manufacturer usually replies in 6 days

rocuronium bromide

Vials, injection 10 mg / ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18007
The objective of the company is to deliver health to all who desire the hands of therapeutic care. This implies the integration of both the goals of the employees and the management philosophy based on a great store of experiences and the customer's fullest trust. The company has received major recognition and awards in recent times.

Manufacturer usually replies in 5 days

rocuronium bromide

Solution for injection 50mg/5ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Manufacturer #16167

Manufacturer usually replies in 7 days

rocuronium bromide

Solution for injection 10 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply
Manufacturer #10323

Manufacturer usually replies in 5 days

rocuronium bromide

Solution for injection 50 mg/5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #13135
The company has become a respected global health care group. The company has great growth potential. They use DDS source technology and an excellent pipeline to secure long-term growth. They are focused on profitability in a highly competitive market with new drugs and niche buster product launch technology.

Manufacturer usually replies in 7 days

Want to view all 32 products? Create your free account today!

ROCURONIUM BROMIDE

Rocuronium Bromide is an amino steroid non-depolarizing neuromuscular blocker. It is used as a muscle relaxant in anaesthesia to facilitate tracheal intubation by providing skeletal muscle relaxation. It is commonly required for surgery or mechanical ventilation. This injection is given both inpatients and outpatients in combination with general anaesthesia. It facilitates both rapid sequence and routine tracheal intubation and relaxes skeletal muscles during surgeries or mechanical ventilation.

Rocuronium Bromide is sold under the brand names Zemuron and Esmeron among others. Akzo N.V. was the file company file a patent for preparation for Rocuronium Bromide in the late 1908s. However, it was only approved for use in the USA in 1994 and is marketed under the trade name of Zemuron. However, this medicine was subsequently withdrawn for its use in executions of death row convicts.

Usage and Dosage:

Rocuronium Bromide is only available as an injection. In cases when the patient needs Tyrachael intubation, they are recommended an initial dose of, regardless of the anaesthetic technique, 0.6 mg per kilo of body weight. In some case, a lower dose of 0.45 mg may also be prescribed. Each ML of this injection has 10 mg of Rocuronium bromide and 2 mg of sodium acetate. For patients who need Rapid Sequence Intubation, in case of properly pre-medicated and anaesthetized patients, the recommended dose is 0.6 to 1.2 mg per kilo of body weight. It can provide excellent conditions for intubating most patients within 2 minutes. When being administered as a Continuous Infusion, the initial infusion rate is 10 to 12 mcg per kilo per minute.

The price of Rocuronium Bromide:

In the USA, the consumers have to pay an average retail price of $ 0.65 for a supply of one injection with a 10 ml supply of this injection. The price of significantly cheaper in the developing, for example in India, the cost of a 5ml supply of this medicine will cost less than USD2.

How does Rocuronium Bromide work?

Rocuronium bromide has a rapid onset and an intermediate duration of action. It was made to be a weaker antagonist at the neuromuscular junction than pancuronium. So, its monoquaternary structure and groups attached to I D ring quaternary nitrogen atom. Rocuronium actions compete for cholinergic receptors at the motor endplate. Antagonized by acetylcholinesterase inhibitors, such as neostigmine and edrophonium, its actions competitively binding to nicotinic cholinergic receptors.

Finding Rocuronium bromide Manufacturers and Suppliers:

The best way to find and gain access to Rocuronium bromide manufacturers and Rocuronium bromide suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Rocuronium bromide can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Rocuronium bromide to work with. You can fine-tune your search results using various filters too, letting you search for Rocuronium bromide from specific countries.